Log In
Thursday 20th June 2019

Drug shrinks brain tumour by 50%

27th September 2011

The drug Votubia (everolimus), which has the ability to decrease the size of brain tumours by 50%, has been launched in the UK.

The drug will be available to NHS doctors, who can apply to use the drug to treat children with non-malignant brain tumours linked with the condition tuberous sclerosis complex. Chris Kingswood, head of research at the Tuberous Sclerosis Association, said: "Everolimus is the first licensed product we can offer patients to attack the cause of their debilitating condition; it works by blocking a protein that acts as an important regulator of tumour cell growth." 

Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2019